“If anything kills over 10 million people in the next few decades, it’s most likely to be a highly infectious virus rather than a war – not missiles, but microbes. Part of the reason is we have invested a huge amount in nuclear deterrents, but we’ve actually invested very little in a system to stop an epidemic.”

-Bill Gates

INVEST IN 3 EASY STEPS

Join the OurCrowd platform, create a FREE investor account (accredited investors only).

Browse investment opportunities, review due diligence material.

Invest and receive quarterly updates on your portfolio’s progress.

1 | JOIN

2 | BROWSE

3 | INVEST

OurCrowd is a global venture investing platform that empowers institutions and individuals to invest and engage in emerging companies. The most active venture investor in Israel, OurCrowd vets and selects companies, invests its capital, and provides its global network with unparalleled access to co-invest and contribute connections, talent and deal flow. OurCrowd builds value for its portfolio companies throughout their lifecycles, providing mentorship, recruiting industry advisors, navigating follow-on rounds and creating growth opportunities through its network of multinational partnerships.

With $1.4 billion of committed funding, and investments in 200 portfolio companies and 22 venture funds, OurCrowd offers access to its membership of 45,000 individual accredited and institutional investors, family offices, and venture capital partners from over 183 countries to invest alongside, at the same terms. OurCrowd’s portfolio is diversified across sectors and stages, ranging from seed and Series A through late stage and pre-IPO firms. Since its founding in 2013, OurCrowd portfolio companies have been acquired by some of the most prestigious brands in the world, including Uber, Canon, Oracle, Nike, and Intel.

Learn More About OurCrowd

OurCrowd is a global venture investing platform that empowers institutions and individuals to invest and engage in emerging companies. The most active venture investor in Israel, OurCrowd vets and selects companies, invests its capital, and provides its global network with unparalleled access to co-invest and contribute connections, talent and deal flow. OurCrowd builds value for its portfolio companies throughout their lifecycles, providing mentorship, recruiting industry advisors, navigating follow-on rounds and creating growth opportunities through its network of multinational partnerships.

With $1.4 billion of committed funding, and investments in 200 portfolio companies and 22 venture funds, OurCrowd offers access to its membership of 45,000 individual accredited and institutional investors, family offices, and venture capital partners from over 183 countries to invest alongside, at the same terms. OurCrowd’s portfolio is diversified across sectors and stages, ranging from seed and Series A through late stage and pre-IPO firms. Since its founding in 2013, OurCrowd portfolio companies have been acquired by some of the most prestigious brands in the world, including Uber, Canon, Oracle, Nike, and Intel.

Learn More About OurCrowd

Answer 4 Questions to Get Started.

How It Works

Join by creating a
FREE investor account
(accredited investors only).

Join

1

2 Browse

Browse investment opportunities, review due diligence material.

3 Invest

Invest and receive quarterly updates on your portfolio's progress.

In addition to single-company investments, OurCrowd offers venture capital funds to diversify your portfolio.

Or

Get More Information

Nothing on this website should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by OurCrowd or any third party. You are solely responsible for determining whether any investment, investment strategy, security or related transaction is appropriate for you based on your personal investment objectives, financial circumstances and risk tolerance. Investors and users should consult with licensed legal professionals and investment advisors for any legal, tax, insurance, or investment advice. Please click here for additional details.

Game-changing cancer treatment with Nobel Prize-winning tech

Proton therapy is the most advanced radiotherapy treatment against cancer, but due to the high cost of current systems only 5% of eligible cancer patients have access. HIL Applied Medical is changing that by developing the world’s first and only laser-based proton therapy system. Ultra-compact and up to 65% less expensive to own and operate than existing systems, HIL is working to expand proton therapy to the 1M+ new eligible cancer patients every year.

Bringing innovative tech to a $20B total addressable market, HIL has signed an MOU with Proton International — the largest proton therapy builder and operator in the U.S. and Europe — and is preparing to launch beta systems in hospitals around the world.

As seen on

OurCrowd’s experienced investment team identifies and conducts research on thousands of companies and venture funds to tap into cutting-edge opportunities across sectors and stages.

Join us to access these opportunities to invest alongside OurCrowd and other VCs.